
What drives financial fraud? It can come down to one emotion
It's the 1980s, and a group of young men have dreams of making a fortune.
When Joe Hunt reconnects with his former high school classmates in Los Angeles, he has promises of a new business venture that will make them rich. With visions of wealth and success, the young men are lured into what becomes a web of fraud — and a cautionary tale that devolves into murder.
CNN Original Series' 'Billionaire Boys Club' recounts this tale of greed from Wall Street. It's a dark example of a kind of fraud that has reoccurred throughout modern financial history. It's also a reminder of how aspirations of wealth can be exploited.
Ahead of the series premiere this evening at 9 p.m. ET, CNN spoke with three experts in economics and finance to better understand why greed is persistent in markets, what hidden risks might linger and how to protect your finances from fraudulent schemes.
After Hunt reconnects with his former classmates, including Dean Karny and Ben Dosti, the group starts a new social and investment club. At its core, greed drives their pursuit of wealth and power.
Greed has driven people's actions throughout history, including in the world of finance, said Anat Admati, professor of finance and economics at Stanford Graduate School of Business.
'Greed is about wanting things to own, to consume,' Admati said. 'It's pervasive.'
Capitalism and markets are profit-driven by design. While that framework can produce remarkable wealth and growth, it can also be taken advantage of by bad actors. In the case of the Billionaire Boys Club, Hunt goes down a path that eventually spirals into deception.
Greed can be particularly pervasive in finance because promises of wealth can manipulate people's emotions, Admati said. This can sway them to believe in get-rich-quick opportunities — and fall for Ponzi schemes.
'Money is a source of power and admiration,' she said. 'The culture of wanting wealth and financial success is strong. Then it meets the human psychological feature of wanting to believe things, or wanting to trust people.'
While there are many cautionary tales of deceit, people often fall for fraud because they don't think they could be the one who is being duped, Admati said.
'People are more likely to be tricked into believing things when they don't understand the way claims that are being made to them can be manipulated at the backend,' she said.
The 1980s was an era known for greed on Wall Street, as detailed in the 'Billionaire Boys Club' series; books including 'Barbarians at the Gate,' by journalists Bryan Burrough and Joe Helyar and 'Liar's Poker' by Michael Lewis; and the 1987 movie 'Wall Street.'
In the 21st century, varying degrees of financial deceit — from the Enron accounting scandal to the devastating consequences of massive Ponzi schemes like the one run by Bernie Madoff — continue to impact people across the country. Just last week, the US Securities and Exchange Commission announced it had charged a Georgia-based company with running a $140 million Ponzi scheme.
David Smith, a professor of economics at Pepperdine Graziadio School of Business, said it's often the same, recurring themes of greed that take place in different frameworks.
'As an economist, one of the things we study very carefully is incentives and how they drive human behavior,' Smith said. 'Individuals are driven by different motives, but one of them is to acquire wealth.'
Pure greed and the desire to acquire more wealth or experiences of financial hardship are reasons why a person might commit fraud, Smith said.
And the rise of cryptocurrencies has opened investors to a plethora of new risks and potential scams, according to Hilary Allen, a law professor at American University.
While bitcoin and other crypto have proved profitable for some, there have been numerous instances of memecoins — a functionally worthless asset that trades on hype and often results in investors losing cash. Victims reported more than $5.6 billion in fraud related to cryptocurrency in 2023, a 45% increase from losses reported in 2022, according to an FBI report.
'There's no good reason for it to have value other than the fact that you think that someone else will buy it from you in the future for more than you paid for it,' Allen said. 'And that's pretty Ponzi-like.'
From Wall Street in the 1980s to memecoins in the 2020s, a lack of oversight and regulation can create opportunities for bad actors, Allen said.
'Greed is not new, and greed in financial services is particularly not new, because that's where the money is,' Allen said.
In April, the SEC announced it charged an individual for orchestrating a fraudulent crypto scheme that raised $198 million from investors. Ramil Palafox misappropriated $57 million of investor funds to purchase Lamborghini cars and items from 'luxury retailers,' the SEC said, in addition to engaging in a 'Ponzi-like scheme' until the fraudulent project collapsed.
'Financial markets are at least relatively transparent, whereas cryptocurrency, even though it claims it's built on the backbone of full verification and public display of the blockchain, there are still a lot of opportunities for bad actors to take advantage of the lack of information that exists,' Pepperdine's Smith said. 'There's also the lack of regulation.'
Greed can underpin wild stories of corruption and murder, including the Billionaires Boys Club. But greed and fraud can also arise daily, from phishing emails to online scams.
There are steps people can take to better protect themselves, Smith said. 'If it's too good to be true, it probably is.'
As for why people are drawn to learning about stories of greed and financial fraud, Smith said it gets to a core of human emotion that people can relate to. 'I think we can all empathize with the allure of an opportunity that sounds like a shortcut to something,' he said.
Individuals have to gauge their own risk tolerance for investing in anything, whether it is stocks or crypto, he said, but 'it's always good advice not to expose too much of your underlying financial wealth to a new opportunity.'
'Make sure that you seek good financial advice before you do anything,' he said. 'Talk with a financial advisor, your friends or family members. Oftentimes, the worst financial decisions are made in isolation, where people don't vet their ideas or what's being proposed to them with others.'

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 minutes ago
- Yahoo
Morgan Stanley Maintains a Buy on Exelixis (EXEL) With a $48 PT
Exelixis, Inc. (NASDAQ:EXEL) is one of the most profitable biotech stocks to invest in now. On July 22, Morgan Stanley analyst Sean Laaman maintained a Buy rating on Exelixis, Inc. (NASDAQ:EXEL) and set a price target of $48.00. A team of scientists in lab coats surrounded by pharmaceuticals and medical equipment, researching a life-saving oncology-focused biotechnology. The analyst reasoned that Exelixis, Inc. (NASDAQ:EXEL) recently updated its 2025 revenue guidance, increasing it to a $2.25-2.35 billion range after the higher-than-expected sales of Cabo. He attributed this optimistic outlook to the persistent demand growth and new patient starts in first-line renal cell carcinoma (1L RCC). Laaman also stated that Exelixis, Inc. (NASDAQ:EXEL) reported that it may update its guidance further as the NET launch progresses and additional revenue opportunities become clearer. Exelixis, Inc. (NASDAQ:EXEL) discovers, develops, and commercializes new medicines for difficult-to-treat cancers. Its product portfolio includes cabometyx, cometriq, and cotellic. While we acknowledge the potential of EXEL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
Yahoo
4 minutes ago
- Yahoo
The Open Group Launches The Open Group Open Digital Transformation™ Forum
Standards body aims to spur faster, more effective transformation initiatives SAN FRANCISCO, July 28, 2025--(BUSINESS WIRE)--The Open Group, the vendor-neutral technology consortium, has today announced the formation of The Open Group Open Digital Transformation™ Forum (ODXF). This new initiative will support enterprise Digital Transformation by developing and popularizing pragmatic, open standards in this increasingly valuable and challenging space. By establishing clear guidelines for Digital Transformation initiatives and enabling cross-industry collaboration to share insights and best practices, ODXF aims to ensure that a greater share of Digital Transformation investment globally delivers effective returns on investment and measurably positive impacts on cultural, workforce, and technological changes. "The vast majority of enterprises today are engaged in Digital Transformation initiatives, with significant global spend in Digital Transformation," commented Rashed Al-Yami, Governing Board Member of The Open Group and Manager Digital Platforms & Architecture Design Division at Aramco. "By developing open standards through vendor-neutral collaboration, ODXF can influence the Digital Transformation agenda towards more rigorous and successful practices." Key focus areas for ODXF include developing standardized frameworks for Digital Transformation initiatives, ensuring consistency, and producing reference architectures which organizations can incorporate in order to make their own Digital Transformation journeys more agile and responsive. The Forum will also collaborate on establishing a body of knowledge, which incorporates a range of documents designed to help users operationalize the standard, as well as ultimately delivering a certification program for practitioners to demonstrate that they understand and can apply best-in-class approaches to Digital Transformation. "Digital Transformation is not a new term, but the emergence of a range of disruptive technologies, from AI to quantum computing, has made it more urgent than ever for businesses to find a clear guiding path towards proven approaches to this challenge," said Steve Nunn, President and CEO of The Open Group. "Our track record of bringing industry stakeholders together in a neutral, collaborative space means that The Open Group is well placed to add value to one of the world's major areas of investment." To learn more about The Open Group Open Digital Transformation Forum, please visit here. About The Open Group The Open Group is a global consortium that enables the achievement of business objectives through technology standards and open source initiatives by fostering a culture of collaboration, inclusivity, and mutual respect among our diverse group of 900+ memberships. Our Membership includes customers, systems and solutions suppliers, tool vendors, integrators, academics, and consultants across multiple industries. View source version on Contacts Media contact Monika BoudovaHotwire for The Open GroupUKOpengroup@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
4 minutes ago
- Yahoo
RBC Capital Sees Strong Growth Potential for Abbott Laboratories (ABT)
Abbott Laboratories (NYSE:ABT) ranks among the . RBC Capital maintained its Outperform rating on Abbott Laboratories (NYSE:ABT) on July 15 and raised its price target from $145 to $147. The firm pointed to Abbott's strong single-digit revenue and double-digit EPS growth potential as examples of its ability to provide top-tier financial growth in the medical technology industry. According to RBC Capital's intra-quarter checks, Abbott Laboratories (NYSE:ABT) maintains positive healthcare utilization in Q2. Moreover, Abbott's diabetes brand, which has been attracting a lot of investor interest, was one of the several growth catalysts mentioned in the firm's report. The less elective nature of Abbott's medical device portfolio was also mentioned by RBC as a benefit. RBC Capital's sustained belief in Abbott Laboratories (NYSE:ABT) as the best-performing large cap in its coverage year-to-date is bolstered by other positives such as business momentum in diabetes care, favorable trends in diagnostics, stability in nutrition, and strength in established pharmaceuticals. Abbott Laboratories (NYSE:ABT) is a leading global healthcare company that manufactures a wide range of branded generic medications, medical devices, diagnostics, and nutritional items. While we acknowledge the potential of ABT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. Read More: and Disclosure: None. Sign in to access your portfolio